OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis
Jian Zheng, Xiaoxi Li, Cunwei Cai, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3005-3016
Open Access | Times Cited: 13
Jian Zheng, Xiaoxi Li, Cunwei Cai, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3005-3016
Open Access | Times Cited: 13
Showing 13 citing articles:
Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
Zixu Zhang, David Westover, Zhantong Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Zixu Zhang, David Westover, Zhantong Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
The SLIT/ROBO Pathway in Liver Fibrosis and Cancer
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 785-785
Open Access | Times Cited: 19
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 785-785
Open Access | Times Cited: 19
Transcription Factor FOSL1 Promotes Cisplatin Resistance in Non-Small Cell Lung Cancer Cells by Modulating the Wnt3a/β-Catenin Signaling through Upregulation of PLIN3 Expression
Wenxue Tong, Jianjun Sun, Bin Shen, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Wenxue Tong, Jianjun Sun, Bin Shen, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
The role of Wnt/β-catenin signaling in lung cancer progression and therapy: a comprehensive review
Fares E.M. Ali, Khalid S.A. Badran, Mostafa S. Abd El‐Maksoud, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Fares E.M. Ali, Khalid S.A. Badran, Mostafa S. Abd El‐Maksoud, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175781-175781
Closed Access | Times Cited: 8
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175781-175781
Closed Access | Times Cited: 8
Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
Shuyuan Li, Hongliang Zhou, Cheng Hu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
Shuyuan Li, Hongliang Zhou, Cheng Hu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression
Xinbing Yang, Yajing Du, Lulu Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13909-13909
Open Access | Times Cited: 4
Xinbing Yang, Yajing Du, Lulu Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13909-13909
Open Access | Times Cited: 4
RETRACTED ARTICLE: Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family member 1
Libin Zhang, Hao Peng, Zheyuan Xu, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 1814-1827
Open Access | Times Cited: 9
Libin Zhang, Hao Peng, Zheyuan Xu, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 1814-1827
Open Access | Times Cited: 9
Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 1, pp. 94-113
Closed Access | Times Cited: 2
Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 1, pp. 94-113
Closed Access | Times Cited: 2
NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer
Yu Dong, Tao Xu, Dongfan Li, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14413-14425
Open Access | Times Cited: 3
Yu Dong, Tao Xu, Dongfan Li, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14413-14425
Open Access | Times Cited: 3
Study on Cantharidin Reversing the Drug-resistance of Nonsmall Cell Lung Cancer to DDP by Regulating the Expression of PD-L1
Xing Jin, Chun-Hui Ma, Xiaojing Tan, et al.
Pharmacognosy Magazine (2024)
Closed Access
Xing Jin, Chun-Hui Ma, Xiaojing Tan, et al.
Pharmacognosy Magazine (2024)
Closed Access
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness
Marcel Werner, Anna Dyas, Iwan Parfentev, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 2
Marcel Werner, Anna Dyas, Iwan Parfentev, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 2
